Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Radivone 1.5mg/ml Injection

Prescription Icon
Prescription Required

Marketer

Bion Therapeutics India Pvt Ltd

Salt Composition

Edaravone (1.5mg/ml)

Overview Radivone 1.5mg/ml Injection

Nerix 1.5mg/ml Injection aids in managing amyotrophic lateral sclerosis (ALS), a debilitating neurological condition causing muscle weakness and functional impairment. This antioxidant medication helps retard nerve cell deterioration and potentially slows disease advancement. Nerix 1.5mg/ml Injection is administered intravenously by a medical professional and is not for self-injection; it's reserved for situations where oral intake is infeasible. Follow your physician's prescribed dosage and schedule; if a dose is missed, take it promptly upon recollection. Commonly reported side effects include cephalalgia, ecchymosis, and gait abnormalities. Injection site reactions—pain, erythema, or edema—may also occur, but typically resolve spontaneously. Consult your doctor if these persist or are troublesome. Seek immediate medical help if allergic reactions, such as pruritus or swelling of the face, lips, or tongue, develop.

Uses of Radivone 1.5mg/ml Injection

Lou Gehrig's disease

Major Benefits of Radivone 1.5mg/ml Injection:

This medication will be administered by your physician or their qualified staff; self-medication is strictly prohibited.

Common Side effects of Radivone 1.5mg/ml Injection:

  • Bruise
  • Walking difficulties
  • Headache
  • Injection site reactions (pain, swelling, redness)

How to use Radivone 1.5mg/ml Injection:

This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.

How Radivone 1.5mg/ml Injection works:

Radivone 1.5mg/ml Injection, an antioxidant, offers neuroprotective and nootropic benefits. Its mechanism involves mitigating nerve damage from free radical attack, thus slowing ALS symptom progression. This effect is achieved by counteracting oxidative stress, the harmful imbalance between antioxidants and free radicals, within the brain.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The safety of combining alcohol with Radivone 1.5mg/ml Injection is undetermined. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Radivone 1.5mg/ml Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the use of Radivone 1.5mg/ml Injection while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

Radivone 1.5mg/ml Injection's impact on driving ability is undetermined. Refrain from driving if you develop symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Data regarding the use of Radivone 1.5mg/ml Injection in individuals with renal impairment is scarce. Physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should receive Radivone 1.5mg/ml Injection cautiously, with potential dose modification. For these patients, data on Radivone 1.5mg/ml Injection use is limited. Medical advice is recommended. Dosage changes are not usually necessary for individuals experiencing mild to moderate liver dysfunction.

What if you forget to take Radivone 1.5mg/ml Injection :

NA

Facts to Know About Radivone 1.5mg/ml Injection

LabelValue
Chemical Type Pyrazolone Derivatives
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Action Class Cognitive enhancer

FAQs on Radivone 1.5mg/ml Injection

Radivone 1.5mg/ml Injection may cause confusion, headache, and gait disturbance. Less frequent side effects include skin rash or itching, shortness of breath, chest tightness, wheezing, cough (particularly in asthmatics), and fungal infections.
Radivone 1.5mg/ml Injection is a solution administered intravenously over 60 minutes by a healthcare professional in a clinical setting. Initially, it's given daily for 14 days of a 28-day cycle. Subsequent cycles involve daily administration for the first 10 days of a 28-day cycle. Dosage frequency is determined by your doctor based on your response to treatment.
Radivone 1.5mg/ml Injection treats amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease causing muscle weakness and atrophy due to the deterioration of motor neurons. It works by slowing the progression of nerve damage associated with ALS symptom worsening.
Tell your doctor or pharmacist if you're allergic to edaravone, sodium bisulfite, other medications, or any Radivone 1.5mg/ml Injection ingredient. Before taking Radivone, inform your doctor of all other medications, vitamins, and supplements you are using or plan to use; they may need to adjust dosages or monitor you closely. Also, tell your doctor about any history of asthma, and if you are pregnant, plan to become pregnant, or are breastfeeding. Contact your doctor immediately if you become pregnant while using edaravone.
While the preventability of ALS remains unproven due to a lack of supporting studies, mitigating risk factors may lower the likelihood of developing the disease. These factors include smoking and exposure to pesticides and insecticides. Furthermore, military service has also been identified as a potential risk factor.
People of Caucasian and non-Hispanic descent have the highest incidence of amyotrophic lateral sclerosis (ALS). Between 5 and 10 percent of ALS cases are inherited. Onset can occur at any age, though symptoms typically appear between ages 55 and 75. Men are slightly more prone to ALS than women, a difference that lessens with age. Research indicates military veterans may face a 1.5 to 2 times greater risk due to potential wartime toxin exposure.
Exposure to toxins from warfare or intense physical exertion may heighten the risk of ALS in veterans and athletes, researchers propose.
ALS often begins with subtle muscle issues: twitches in limbs or tongue, cramps, stiffness, and weakness in an arm, leg, neck, or diaphragm. Speech may become slurred or nasal, and swallowing difficult. Many first notice hand or arm weakness, struggling with tasks like buttoning a shirt or turning a key. Alternatively, leg weakness can be the initial symptom, manifesting as clumsiness while walking, increased tripping, or stumbling.
Radivone 1.5mg/ml Injecti...
337
MRP 390
13% off